Its former vice president of drug development filed a wrongful-termination suit against the company in March 2012, alleging that he was fired after repeatedly complaining to Chioini about possible violations of SEC and Food and Drug Administration rules.
Dr. Richard C. Yocum said in the suit that Rockwell and Chioini knowingly issued false and misleading press releases about the progress of the SFP program. The judge hearing the case ruled in favor of the company, saying it was within its legal rights to fire Yocum and that there was an “absence of evidence” that he was fired in retaliation for claims of improper activity.
The judge did not rule on the validity of Yocum’s claim that Rockwell made false and misleading statements regarding the SFP program.
SFP. Lets start calling it Triferic the name the FDA has approved. Which reminds me. If the FDA has approved a name for SFP doesnt that mean your lawsuit is frivolous?? Get a clue dip #$%$.